نتایج جستجو برای: promoter vector

تعداد نتایج: 282407  

2011
Mohammad Feraz Ahsan Milind M Gore

BACKGROUND Antigen presentation by non professional antigen presenting cells (APC) can lead to anergy. In genetic vaccines, targeting the macrophages and APC for efficient antigen presentation might lead to balanced immune response. One such approach is to incorporate APC specific promoter in the vector to be used. METHODS Three promoters known to be active in macrophage were selected and clo...

Journal: :Journal of molecular microbiology and biotechnology 2002
Christopher J Wilkinson Zoë A Hughes-Thomas Christine J Martin Ines Böhm Tatiana Mironenko Matthew Deacon Michael Wheatcroft Gabriele Wirtz James Staunton Peter F Leadlay

An Escherichia coli-actinomycete shuttle vector, pCJW93, was constructed which places cloned genes under the control of the thiostrepton-inducible tip promoter from Streptomyces lividans. We also constructed expression vectors bearing the actII-ORF4/PactI activator-promoter system of the actinorhodin biosynthetic pathway of Streptomyces coelicolor. With both types of vector, levels of expressio...

Journal: :BioTechniques 2007
Soizik Berlivet Virginie Guiraud Martin Houlard Matthieu Gérard

RNA interference (RNAi) is a powerful method to generate loss-of-function phenotypes. Plasmid vectors with RNA polymerase III promoters have been developed to express short hairpin RNAs (shRNAs) in mammalian cells. In order to optimize the efficiency of these vectors in embryonic stem (ES) cells, we have constructed and tested several plasmids, based on the H1 promoter; that direct the expressi...

2012
Xin-Ran Liu Ying Cai Xin Cao Rui-Cheng Wei Hui-Ling Li Xiu-Mei Zhou Kang-Jian Zhang Shuai Wu Qi-Jun Qian Biao Cheng Kun Huang Xin-Yuan Liu

Cancer Targeting Gene-Viro-Therapy (CTGVT) is a promising cancer therapeutical strategy that strengthens the anti-tumour effect of oncolytic virus by expressing inserted foreign anti-tumour genes. In this work, we constructed a novel adenoviral vector controlled by the tumour-specific survivin promoter on the basis of the ZD55 vector, which is an E1B55KD gene deleted vector we previously constr...

Journal: :Blood 2003
William R Staplin Joseph A Knezetic

Congenital blood disorders are common and yet clinically challenging globin disorders. Gene therapy continues to serve as a potential therapeutic method to treat these disorders. While tremendous advances have been made in vivo, gene delivery protocols and vector prototypes still require optimization. Alternative cis-acting promoter elements derived from VL30 retroelements have been effective i...

Journal: :International journal of clinical and experimental medicine 2012
Doron Amit Abraham Hochberg

BACKGROUND The human IGF2-P4 and H19 promoters are highly active in a variety of human cancers, while existing at a nearly undetectable level in the surrounding normal tissue. Single promoter vectors expressing diphtheria toxin A-fragment (DTA) under the control regulation of IGF2-P4 or H19 regulatory sequences (IGF2-P4-DTA and H19-DTA) were previously successfully used in cell lines, animal mo...

Journal: :BioTechniques 2004
Mohamed N Seleem Ramesh Vemulapalli Stephen M Boyle Gerhardt G Schurig Nammalwar Sriranganathan

We constructed an improved vector pNSGroE for gene expression studies in Brucella spp. It is derived from the broad host range cloning vector pBBR1MCS (1). This new plasmid has several advantages over pBBR1MCS or its derivatives pBBGroE (2): (i) it is smaller in size, 2.9 kb; (ii) it expresses proteins as His-tagged fusion for easy detection and purification; (iii) it carries the groE promoter ...

Bayat H Ohadi M Valipour E,

Background: We examine the GA-repeat core promoters of MECOM and GABRA3 in human embryonic kidney-293 cell line and show that those GA-repeats have promoter activity,and those different alleles of the repeats can significantly alter gene expression.We propose a novel role for GA-repeat core promoters to regulate gene expression in the genes involved in development and evolution. Materials and M...

2017
Eric W F W Alton Jeffery M Beekman A Christopher Boyd June Brand Marianne S Carlon Mary M Connolly Mario Chan Sinead Conlon Heather E Davidson Jane C Davies Lee A Davies Johanna F Dekkers Ann Doherty Sabrina Gea-Sorli Deborah R Gill Uta Griesenbach Mamoru Hasegawa Tracy E Higgins Takashi Hironaka Laura Hyndman Gerry McLachlan Makoto Inoue Stephen C Hyde J Alastair Innes Toby M Maher Caroline Moran Cuixiang Meng Michael C Paul-Smith Ian A Pringle Kamila M Pytel Andrea Rodriguez-Martinez Alexander C Schmidt Barbara J Stevenson Stephanie G Sumner-Jones Richard Toshner Shu Tsugumine Marguerite W Wasowicz Jie Zhu

We have recently shown that non-viral gene therapy can stabilise the decline of lung function in patients with cystic fibrosis (CF). However, the effect was modest, and more potent gene transfer agents are still required. Fuson protein (F)/Hemagglutinin/Neuraminidase protein (HN)-pseudotyped lentiviral vectors are more efficient for lung gene transfer than non-viral vectors in preclinical model...

2015
Aaron R Cooper Georgia R Lill Eric H Gschweng Donald B Kohn

Lentiviral vectors almost universally use heterologous internal promoters to express transgenes. One of the most commonly used promoter fragments is a 1.2-kb sequence from the human ubiquitin C (UBC) gene, encompassing the promoter, some enhancers, first exon, first intron and a small part of the second exon of UBC. Because splicing can occur after transcription of the vector genome during vect...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید